ES2142791T3 - Complejo de principios activos para la obtencion de partes biologicas, en especial de organos para seres vivos, procedimiento para la obtencion de los mismos, y su empleo. - Google Patents

Complejo de principios activos para la obtencion de partes biologicas, en especial de organos para seres vivos, procedimiento para la obtencion de los mismos, y su empleo.

Info

Publication number
ES2142791T3
ES2142791T3 ES90914898T ES90914898T ES2142791T3 ES 2142791 T3 ES2142791 T3 ES 2142791T3 ES 90914898 T ES90914898 T ES 90914898T ES 90914898 T ES90914898 T ES 90914898T ES 2142791 T3 ES2142791 T3 ES 2142791T3
Authority
ES
Spain
Prior art keywords
obtaining
complex
procedure
themselves
living beings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90914898T
Other languages
English (en)
Inventor
Karlheinz Prof Dr Dr Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2142791T3 publication Critical patent/ES2142791T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Prostheses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL COMPLEJO DE SUSTANCIA ACTIVA PARA LA PRODUCCION DE PARTES BIOLOGICAS, ESPECIALMENTE ORGANOS PARA ORGANISMOS VIVIENTES, INCLUYE UN COMPONENTE ESTRUCTURAL, AL MENOS UN COMPONENTE DE RESTABLECIMIENTO, AL MENOS UN COMPONENTE DE ADHESION Y AL MENOS UN COMPONENTE DE CRECIMIENTO Y/O MADURACION, PREFERIBLEMENTE EN FORMA DE AL MENOS UN CITOQUINO. ESTE COMPLEJO DE SUSTANCIA ACTIVA SE PUEDE PRODUCIR MEDIANTE LA CO-PRECIPITACION DE ESTOS VARIOS COMPONENTES O POR LIOFILIZACION O POR ENLACE COVALENTE DE LOS COMPONENTES INDIVIDUALES JUNTOS. EL USO DEL COMPLEJO DE SUSTANCIA ACTIVA SE REFIERE A LA PRODUCCION DE UNA PARTE BIOLOGICA PARA EL TRATAMIENTO DE ENFERMEDADES CAUSADAS POR LA CARENCIA DE ESTA PARTE BIOLOGICA O DE SU MAL FUNCIONAMIENTO.
ES90914898T 1989-11-03 1990-10-12 Complejo de principios activos para la obtencion de partes biologicas, en especial de organos para seres vivos, procedimiento para la obtencion de los mismos, y su empleo. Expired - Lifetime ES2142791T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3936568A DE3936568C2 (de) 1989-11-03 1989-11-03 Wirkstoffkomplex für die Herstellung von biologischen Teilen in Form von Organen für Lebewesen; Verfahren zum Herstellen desselben und seine Verwendung

Publications (1)

Publication Number Publication Date
ES2142791T3 true ES2142791T3 (es) 2000-05-01

Family

ID=6392769

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90914898T Expired - Lifetime ES2142791T3 (es) 1989-11-03 1990-10-12 Complejo de principios activos para la obtencion de partes biologicas, en especial de organos para seres vivos, procedimiento para la obtencion de los mismos, y su empleo.

Country Status (12)

Country Link
US (1) US5932207A (es)
EP (1) EP0500556B1 (es)
JP (1) JP3626178B2 (es)
KR (1) KR100195549B1 (es)
AT (1) ATE188877T1 (es)
BR (1) BR9007808A (es)
DE (2) DE3936568C2 (es)
DK (1) DK0500556T3 (es)
ES (1) ES2142791T3 (es)
GR (1) GR3032800T3 (es)
RU (1) RU2093191C1 (es)
WO (1) WO1991006324A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071655A (en) * 1990-01-12 1991-12-10 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
RU2121370C1 (ru) * 1992-04-11 1998-11-10 Шмидт Карлхайнц Способ получения активного комплекса биологического назначения
DE19917696A1 (de) * 1999-04-20 2000-10-26 Karlheinz Schmidt Mittel für die Herstellung biologischer Teile mit einem Wirkstoffkomplex und für diesen geeigneten Trägermaterialien
US7214654B1 (en) * 1994-12-07 2007-05-08 Karlheinz Schmidt Agent for the manufacture of biological parts including an active ingredient complex and carrying materials suitable for the active ingredient complex
US5928635A (en) * 1994-12-07 1999-07-27 Schmidt; Karlheinz Process for producing active agent complexes
US6989033B1 (en) 1992-09-17 2006-01-24 Karlheinz Schmidt Implant for recreating verterbrae and tubular bones
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
JP2002306518A (ja) * 2000-12-21 2002-10-22 Yuichi Mori 体内留置用具
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
KR100487693B1 (ko) * 2001-11-27 2005-05-06 (주)리젠메드 골아세포의 부착을 촉진하는 자연골 대체용 인공골 구조재료
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
US20070178137A1 (en) * 2006-02-01 2007-08-02 Toby Freyman Local control of inflammation
US7556210B2 (en) * 2006-05-11 2009-07-07 S. C. Johnson & Son, Inc. Self-contained multi-sprayer
US7718616B2 (en) * 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8114428B2 (en) 2007-03-08 2012-02-14 Sbf Synthetic Bone Factory Gmbh Methods for manufacturing a composition for treating bone and/or cartilage defects
DE102007012276A1 (de) * 2007-03-08 2008-09-11 Sbf Synthetic Bone Factory Gmbh Zusammensetzung zur Behandlung von Knochen- und/oder Knorpeldefekten
AU2011329054B2 (en) 2010-11-15 2015-05-28 Zimmer Orthobiologics, Inc. Bone void fillers

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929144A1 (de) * 1979-07-19 1981-02-12 Behringwerke Ag Verfahren zur herstellung von kollagen
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US4472840A (en) * 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
WO1984000540A1 (en) * 1982-08-04 1984-02-16 Jolla Cancer Res Found Polypeptide
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US4932973A (en) * 1983-09-30 1990-06-12 El Gendler Cartilage and bone induction by artificially perforated organic bone matrix
IL74715A0 (en) * 1984-03-27 1985-06-30 Univ New Jersey Med Biodegradable matrix and methods for producing same
US4925924A (en) * 1984-03-27 1990-05-15 University Of Medicine And Dentistry Of New Jersey Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof
US4681763A (en) * 1985-06-11 1987-07-21 University Of Medicine And Dentistry Of New Jersey Composition for stimulating bone growth
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US4693718A (en) * 1985-10-31 1987-09-15 University Of Alabama In Birmingham Stimulation of chemotaxis by chemotactic peptides
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US5019087A (en) * 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5154931A (en) * 1986-10-22 1992-10-13 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Growth-stimulating material derived from porcine bone therefor and a manufacturing process
US5041138A (en) * 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
DE3709101A1 (de) * 1987-03-20 1988-09-29 Mueller Lierheim Kg Biolog Lab Immobilisierungssubstanz
US4863732A (en) * 1987-12-16 1989-09-05 Collagen Corporation Injectable composition for inductive bone repair
GB2215209B (en) * 1988-03-14 1992-08-26 Osmed Inc Method and apparatus for biodegradable, osteogenic, bone graft substitute device
US4973466A (en) * 1988-06-21 1990-11-27 Chiron Ophthalmics, Inc. Wound-healing dressings and methods
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
FR2637502A1 (fr) * 1988-10-12 1990-04-13 Duroselle Patrick Materiau de xenogreffe osseuse et procede d'obtention

Also Published As

Publication number Publication date
DE3936568C2 (de) 1997-06-19
KR920703134A (ko) 1992-12-17
RU2093191C1 (ru) 1997-10-20
WO1991006324A1 (de) 1991-05-16
DE59010894D1 (de) 2000-02-24
ATE188877T1 (de) 2000-02-15
KR100195549B1 (ko) 1999-06-15
DE3936568A1 (de) 1991-05-08
BR9007808A (pt) 1992-09-29
JPH05501208A (ja) 1993-03-11
DK0500556T3 (da) 2000-05-22
JP3626178B2 (ja) 2005-03-02
GR3032800T3 (en) 2000-06-30
US5932207A (en) 1999-08-03
EP0500556B1 (de) 2000-01-19
EP0500556A1 (de) 1992-09-02

Similar Documents

Publication Publication Date Title
ES2142791T3 (es) Complejo de principios activos para la obtencion de partes biologicas, en especial de organos para seres vivos, procedimiento para la obtencion de los mismos, y su empleo.
IT8467249A0 (it) Protesi valvolare cardiaca provvista di lembi valvolari di tessuto biologico
NO170194C (no) Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ATE15590T1 (de) Gerader, blattartiger schaft fuer eine gelenkendoprothese.
DE69029257D1 (de) Anordnung zur bestrahlung von laserstrahlen
GB2197329B (en) Hard tissue substitute composition
DE3581407D1 (de) Bewahrung lebender gewebe.
ES2013639B3 (es) Nuevas composiciones tensioactivas a base de esteres fosforicos, su procedimiento de preparacion y su aplicacion a la formulacion de materias activas.
DE58905850D1 (de) Katheter für die perkutane gefäss- und organchirurgie mittels energiestrahlung.
UY23665A1 (es) Procedimiento para la preparacion de compuesto farmaceutico
DK323886A (da) Indretning til styret vaevvaekst ind i kirurgisk intervenerede omraader
NO163776C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazoquinoksaliner.
NL177501C (nl) Inrichting voor het kweken van dierlijke en menselijke weefsels in de vorm van eencellige lagen en van virussen op deze weefselcultures.
JPS62172408U (es)
ATA768477A (de) Werkzeug zur chirurgischen vorbereitung der implantation eines implantats zur befestigung von festsitzendem zahnersatz
CY1105838T1 (el) Ενδοπροθεση με σταθepοποιηση μακρας διαρκειας
ES2179960T3 (es) Solucion de conservacion para organos o tejidos, o partes de los mismos, de seres humanos o animales.
TW363887B (en) Surgical implement
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
ES491307A0 (es) Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal
KR890701094A (ko) 활성성분의 피부조직 전이흡수를 보장하는 약제학적 제제형 및 그 조제방법
ES2044842T3 (es) Matriz de soporte de colageno topico biologicamente activo, usos cosmeticos y farmaceuticos y un procedimiento para su preparacion.
ES2150902T3 (es) Procedimientos para potenciar la cicatrizacion de heridas y la reparacion de tejidos.
DK157035C (da) Biologisk ren mikroorganismestamme samt fremgangsmaade til fremstilling af et dyrkningsprodukt heraf til anvendelse som et hudpraeparat

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 500556

Country of ref document: ES